Amgen partners with Cytokinetics on heart failure drug; deal ends
Amgen has teamed up with Cytokinetics (developing small-molecule therapeutics that focus on the cytoskeleton) to discover, develop, and market small-molecule heart failure pharmaceuticals globally, excluding Japan. The companies will create compounds that activate cardiac muscle contractility.
- Includes Equity
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com